Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report

Abstract Background Immune checkpoint inhibitor (ICI) therapy is used in the management of advanced malignancies. Thyroid function abnormalities have been reported, but more evidence is needed to substantiate the subtypes and course of thyroid disease associated with this treatment. Case presentatio...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Marco Juul Thomsen, Stine Linding Andersen, Nanna Maria Uldall Torp, Stig Andersen, Allan Carlé
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-07-01
Schriftenreihe:	Thyroid Research
Schlagworte:	PD-1 CTLA-4 Immune-related adverse events Hypothyroidism Hyperthyroidism
Online-Zugang:	https://doi.org/10.1186/s13044-025-00254-7
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!